Mapping the ABC transporter landscape in the human lung: A comprehensive characterisation of P-gp, MRP1 and BCRP expression and functional activity in human lung epithelial cells

Active efflux transporters can play a substantial role in the drug disposition of their substrates in the human body. Efflux transporters like P-glycoprotein (P-gp), multidrug resistance associated protein 1 (MRP1) and breast cancer resistance protein (BCRP) were described to be expressed in the human lung. However, there is conflicting data reported regarding their expression and functional activity in the human lung epithelium in vitro. In this study, the expression and functional efflux of P-gp, MRP1 and BCRP was investigated in cell lines and primary cells derived from human upper (16HBE14o-, Calu-3, NHBE) and lower airways (NCI-H441, A549, hAELVi, Arlo and hAEpC). Additionally, the impact of culture condition, air liquid interface (ALI) vs liquid covered condition (LCC), on transporters' expression levels and efflux was evaluated. Gene and protein expression analysis revealed a ubiquitous expression of MRP1, while BCRP was present in most cells, except Calu-3, Arlo and hAEpC and P-gp was absent in all cells apart from Calu-3. Culturing the cells at ALI vs. LCC condition had only a significant impact on P-gp and MRP1 protein expression levels in Calu-3, which were both reduced at LCC. The functional activity of the expressed efflux transporters was demonstrated by the intracellular accumulation of fluorophore substrates in the absence and presence of transporter specific inhibitors. However, bidirectional transport studies using drug substrates did not result in any observed efflux mediated by MRP1 and BCRP across any of the lung epithelial cells. Only P-gp, expressed in Calu-3 at ALI, showed functional activity in this experimental setting. In addition, it was observed that not all tested cells are suitable for studying pulmonary drug disposition processes in vitro due to their inability to form a tight cell barrier. Overall, the results of this study indicate differences in drug transporters' expression levels across human lung epithelial cells. Moreover, the efflux of model fluorophores for P-gp, MRP1 and BCRP was determined, whereas no such efflux was observed for MRP1 and BCRP when using drugs as substrates.

Authors

Institutions

Publication Details

Journal
European Journal of Pharmaceutical Sciences
Published
2025-10-17
DOI
https://doi.org/10.1016/j.ejps.2025.107333
Citations
3
Primary Topic
Drug Transport and Resistance Mechanisms
Type
article
Field-Weighted Citation Impact
3.14
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Mapping the ABC transporter landscape in the human lung: A comprehensive characterisation of P-gp, MRP1 and BCRP expression and functional activity in human lung epithelial cells

Claus‐Michael Lehr, Nicole Schneider‐Daum, Carina Cantrill, Tobias Neu et al.
3 citations
European Journal of Pharmaceutical Sciences
Drug Transport and Resistance Mechanisms
3.14
article

Mapping the ABC transporter landscape in the human lung: A comprehensive characterisation of P-gp, MRP1 and BCRP expression and functional activity in human lung epithelial cells

Claus‐Michael Lehr, Nicole Schneider‐Daum, Carina Cantrill, Tobias Neu, Silke Simon, Thanusa Shanmugalingam
article en
3 citations

Abstract

Active efflux transporters can play a substantial role in the drug disposition of their substrates in the human body. Efflux transporters like P-glycoprotein (P-gp), multidrug resistance associated protein 1 (MRP1) and breast cancer resistance protein (BCRP) were described to be expressed in the human lung. However, there is conflicting data reported regarding their expression and functional activity in the human lung epithelium in vitro. In this study, the expression and functional efflux of P-gp, MRP1 and BCRP was investigated in cell lines and primary cells derived from human upper (16HBE14o-, Calu-3, NHBE) and lower airways (NCI-H441, A549, hAELVi, Arlo and hAEpC). Additionally, the impact of culture condition, air liquid interface (ALI) vs liquid covered condition (LCC), on transporters' expression levels and efflux was evaluated. Gene and protein expression analysis revealed a ubiquitous expression of MRP1, while BCRP was present in most cells, except Calu-3, Arlo and hAEpC and P-gp was absent in all cells apart from Calu-3. Culturing the cells at ALI vs. LCC condition had only a significant impact on P-gp and MRP1 protein expression levels in Calu-3, which were both reduced at LCC. The functional activity of the expressed efflux transporters was demonstrated by the intracellular accumulation of fluorophore substrates in the absence and presence of transporter specific inhibitors. However, bidirectional transport studies using drug substrates did not result in any observed efflux mediated by MRP1 and BCRP across any of the lung epithelial cells. Only P-gp, expressed in Calu-3 at ALI, showed functional activity in this experimental setting. In addition, it was observed that not all tested cells are suitable for studying pulmonary drug disposition processes in vitro due to their inability to form a tight cell barrier. Overall, the results of this study indicate differences in drug transporters' expression levels across human lung epithelial cells. Moreover, the efflux of model fluorophores for P-gp, MRP1 and BCRP was determined, whereas no such efflux was observed for MRP1 and BCRP when using drugs as substrates.

European Journal of Pharmaceutical SciencesVol. 215
Roche (Switzerland) (CH), Helmholtz Institute for Pharmaceutical Research Saarland (DE)
Openalex Percentile: Top 7%
Drug Transport and Resistance Mechanisms
3.14
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.